Corresponding Author: Zhongjun Wu
Department of Hepatobiliary Surgery, The 1st Affiliated Hosp. of Chongqing Med. Univ.
Chongqing 400016 (China)
“Role of miR-148a in Mitigating Hepatic Ischemia-Reperfusion Injury by Repressing the TLR4 Signaling Pathway via Targeting CaMKIIα in Vivo and in Vitro”
[Cell Physiol Biochem 2018;49:2060-2072. DOI: 10.1159/000493716]
by Daofeng Zheng, Zhongtang Li, Xufu Wei, Rui Liu, Ai Shen, Diao He, Chengyong Tang and Zhongjun Wu
has been retracted by the current and former Publisher and the Editor.
Following publication, image duplication was identified within Figure 4C. Figure 1E P-TAK1 was found to be published in another article by the first author. When asked to comment, the corresponding author stated that images in Figures 1E, 2E, 3B and 4C were mislabelled at acquisition and, consequently, the associated graphs and results were not correct. As the underlying data for this article did not reflect the conditions described in the article, the results can not be relied on and the article is being retracted.
The corresponding author, on behalf of all authors, agrees with this retraction.